Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Landscape of Prostate Tumour Methylation.

Cancer discovery·2026
Same author

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy.

Molecular therapy. Advances·2026
Same author

Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.

JCO precision oncology·2026
Same author

Reviewing the 60/60 referral criteria for cochlear implant candidacy evaluation in the Australian context.

International journal of audiology·2026
Same author

Macrothrombocytopaenia: More to Fear Than Just Low Platelet Count.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

The Landscape of Prostate Tumour Methylation.

bioRxiv : the preprint server for biology·2025
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K

Prostate Cancer Genomic Subtypes.

Michael Fraser1, Alexandre Rouette2

  • 1Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada. Michael.Fraser@oicr.on.ca.

Advances in Experimental Medicine and Biology
|January 5, 2020
PubMed
Summary
This summary is machine-generated.

Advancements in cancer genomics reveal crucial molecular subtypes driving prostate cancer. Understanding these genetic changes, in both somatic and germline DNA, can personalize treatment and predict patient outcomes.

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.1K
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

652

Related Experiment Videos

Last Updated: Dec 31, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.1K
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

652

Area of Science:

  • Genomic Medicine
  • Cancer Biology
  • Computational Biology

Background:

  • Massively-parallel DNA sequencing and computational biology have revolutionized cancer research.
  • Major cancer genomics consortia like TCGA and ICGC provide extensive datasets for analysis.
  • These resources enable correlative studies and hypothesis testing in large patient cohorts.

Purpose of the Study:

  • To review the impact of technological advancements on understanding prostate cancer molecular subtypes.
  • To focus on subtypes influencing prostate cancer initiation, progression, metastasis, and clinical aggression.
  • To assess how somatic and germline genomic subtypes affect individual patient outcomes.

Main Methods:

  • Review of data from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC).
  • Analysis of mutational, pathological, and clinical data through web-based portals.
  • Focus on correlative studies and hypothesis testing using well-powered patient cohorts.

Main Results:

  • Identification of key molecular subtypes driving prostate cancer development and progression.
  • Characterization of subtypes associated with metastasis and clinical aggression.
  • Correlation of specific genomic alterations with patient cohort characteristics.

Conclusions:

  • Technological advancements have significantly deepened the understanding of prostate cancer's molecular landscape.
  • Molecular subtypes, defined by somatic and germline alterations, are critical for stratifying patients.
  • Improved understanding of these subtypes holds promise for personalized treatment strategies and improved clinical management of prostate cancer.